Publisher
Springer Berlin Heidelberg
Reference16 articles.
1. Ciafaloni E. Myasthenia gravis and congenital myasthenic syndromes. Continuum (Minneap Minn). 2019;25:1767–84.
2. Hamedani AG, Pistilli M, Singhal S, et al. Outcomes after transcervical thymectomy for ocular myasthenia gravis: a retrospective cohort study with inverse probability weighting. J Neuroophthalmol. 2020;40:8–14.
3. Hendricks TM, Bhatti MT, Hodge DO, et al. Incidence, epidemiology, and transformation of ocular myasthenia gravis: a population based study. Am J Ophthlmol. 2019;205:99–105.
4. Howard JF Jr, Utsugisawa K, Benatar M, et al. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study. Lancet Neurol. 2017;16:976–86.
5. Johnson NE. Myotonic Muscular Dystrophies. Continuum (Minneap Minn). 2019;25:1682–95.